全文获取类型
收费全文 | 14860篇 |
免费 | 1373篇 |
国内免费 | 1066篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 155篇 |
妇产科学 | 165篇 |
基础医学 | 1715篇 |
口腔科学 | 193篇 |
临床医学 | 1940篇 |
内科学 | 2069篇 |
皮肤病学 | 106篇 |
神经病学 | 799篇 |
特种医学 | 478篇 |
外国民族医学 | 10篇 |
外科学 | 1537篇 |
综合类 | 3051篇 |
现状与发展 | 7篇 |
一般理论 | 1篇 |
预防医学 | 900篇 |
眼科学 | 334篇 |
药学 | 1611篇 |
15篇 | |
中国医学 | 895篇 |
肿瘤学 | 1153篇 |
出版年
2024年 | 48篇 |
2023年 | 245篇 |
2022年 | 557篇 |
2021年 | 794篇 |
2020年 | 623篇 |
2019年 | 470篇 |
2018年 | 467篇 |
2017年 | 442篇 |
2016年 | 465篇 |
2015年 | 677篇 |
2014年 | 843篇 |
2013年 | 752篇 |
2012年 | 1140篇 |
2011年 | 1238篇 |
2010年 | 867篇 |
2009年 | 686篇 |
2008年 | 812篇 |
2007年 | 811篇 |
2006年 | 813篇 |
2005年 | 780篇 |
2004年 | 501篇 |
2003年 | 461篇 |
2002年 | 409篇 |
2001年 | 390篇 |
2000年 | 319篇 |
1999年 | 341篇 |
1998年 | 195篇 |
1997年 | 213篇 |
1996年 | 169篇 |
1995年 | 141篇 |
1994年 | 104篇 |
1993年 | 59篇 |
1992年 | 84篇 |
1991年 | 75篇 |
1990年 | 73篇 |
1989年 | 61篇 |
1988年 | 41篇 |
1987年 | 39篇 |
1986年 | 44篇 |
1985年 | 20篇 |
1984年 | 11篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1979年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
氧离子注入增强人工关节软骨材料-UHMWPE的耐磨性 总被引:10,自引:0,他引:10
熊党生 《生物医学工程学杂志》2003,20(4):583-585,596
用高能离子注入机对超高分子量聚乙烯 (U HMWPE)进行了 O+注入改性 ,注入能量为 4 5 0 ke V和 10 0ke V,剂量分别为 1× 10 1 5/cm2 ,5× 10 1 5/cm2和 1× 10 1 6 /cm2。以 Si3N4 球为上销样 ,UHMWPE为下盘样组成摩擦副 ,在销盘摩擦试验机上评价它们在干摩擦和蒸馏水润滑条件下的磨损性能。结果表明 ,几种注入工艺均增强了UHMWPE的耐磨性 ,但提高了其摩擦系数 ,其中以能量为 4 5 0 Ke V,剂量为 5× 10 1 5/cm2的注入样品耐磨性最好。未注入 U HMWPE的磨损主要表现为黏着、塑性变形和犁沟 ,注入 U HMWPE的磨损主要为表面硬化层疲劳裂纹的萌生、扩展、剥落及磨粒磨损 相似文献
72.
本文研究绞股蓝总皂甙对血流动力学及缺氧性肺血管收缩反应的影响。14名男性志愿者口服20日后,基础血流动力学指标无显著变化,但HPV显著降低。服药后血小板活化程度,血浆血管紧张素Ⅰ、Ⅱ含量都明显降低。 相似文献
73.
用噬菌体表面展示技术筛选与肝癌细胞系结合的抗体模拟肽 总被引:1,自引:0,他引:1
目的:从噬菌体展示肽库中,筛选可与肝癌细胞特异性结合的抗体模拟肽。方法:通过生物淘选使噬菌体富集。利用ELISA法,鉴定噬菌体单克隆原种的亲和性,并进行统计学分析。通过竞争ELISA,分析筛选所得抗体模拟肽的结合位点,并进一步分析抗体模拟肽的序列组成。结果:随着淘选次数的增加,出现噬菌体的富集。ELISA的结果显示,相对于正常肝细胞,筛选所得环状7肽对肝癌细胞系SMMC7721和BEL7402均有良好的结合活性(P<0.05),且与SMMC7721细胞的结合活性明显优于与BEL7402细胞的亲和性(P<0.05)。在α=0.01的水平上,7肽单克隆噬菌体原种可明显与scFv竞争结合SMMC7721细胞(0.005
相似文献
74.
75.
76.
Seilicovich A Pisera D Sciascia SA Candolfi M Puntel M Xiong W Jaita G Castro MG 《Current gene therapy》2005,5(6):559-572
Pituitary tumors are the most common primary intracranial neoplasms. Although most pituitary tumors are considered typically benign, others can cause severe and progressive disease. The principal aims of pituitary tumor treatment are the elimination or reduction of the tumor mass, normalization of hormone secretion and preservation of remaining pituitary function. In spite of major advances in the therapy of pituitary tumors, for some of the most difficult tumors, current therapies that include medical, surgical and radiotherapeutic methods are often unsatisfactory and there is a need to develop new treatment strategies. Gene therapy, which uses nucleic acids as drugs, has emerged as an attractive therapeutic option for the treatment of pituitary tumors that do not respond to classical treatment strategies if the patients become intolerant to the therapy. The development of animal models for pituitary tumors and hormone hypersecretion has proven to be critical for the implementation of novel treatment strategies and gene therapy approaches. Preclinical trials using several gene therapy approaches for the treatment of anterior pituitary diseases have been successfully implemented. Several issues need to be addressed before clinical implementation becomes a reality, including the development of more effective and safer viral vectors, uncovering novel therapeutic targets and development of targeted expression of therapeutic transgenes. With the development of efficient gene delivery vectors allowing long-term transgene expression with minimal toxicity, gene therapy will become one of the most promising approaches for treating pituitary adenomas. 相似文献
77.
78.
Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas 总被引:3,自引:0,他引:3
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bastian BC Xiong J Frieden IJ Williams ML Chou P Busam K Pinkel D LeBoit PE 《The American journal of pathology》2002,161(4):1163-1169
Large congenital melanocytic nevi (CMN) are at an increased risk of developing melanoma. Several forms of secondary proliferations can arise in congenital nevi on rare occasions. Although some of these closely resemble melanoma both clinically and histologically, metastasis is rare. We used comparative genomic hybridization to analyze chromosomal aberrations in different types of proliferations arising in CMN and compared them to typical congenital nevi, clear-cut melanomas arising in congenital nevi, as well as primary cutaneous melanomas that were not associated with a CMN. Cases of CMN and CMN with secondary proliferations were assigned to six groups according to the predominant histological pattern: group I, bland congenital nevi (n = 6); group II, congenital nevi with foci of increased cellularity (n = 4); group III, CMN with a proliferation simulating superficial spreading melanoma in situ (n = 3); group IV, CMN with a proliferation simulating nodular melanoma (n = 9); group V, proliferating neurocristic hamartoma (n = 1); and group VI, melanoma arising in congenital nevus (n = 6). No aberrations were found in groups I to III, whereas seven of nine cases of group IV, and one of one case of group V, showed aberrations. In group IV six of seven cases with aberrations (86%) showed numerical aberrations of whole chromosomes exclusively. This pattern differed significantly from the findings in melanoma that arose within CMN (n = 6), group VI, or independent of CMN (n = 122) in which only 5% showed numerical changes only. The single case in group V showed aberrations similar to melanoma. The finding of frequent numerical chromosomal aberrations in atypical nodular proliferations arising in CMN identifies these as clonal neoplasms with a genomic instability consistent with a mitotic spindle checkpoint defect. This difference compared to the aberration pattern found in melanoma might explain their more benign clinical behavior and may be of diagnostic value in ambiguous cases. 相似文献
79.
API0134对大鼠血浆和血小板血栓素B2生成与血小板聚集的影响 总被引:2,自引:0,他引:2
用放射免疫分析法和比浊法测定PAI0134对大鼠血浆血栓素B2浓度,血小板TXB2生成血小板聚集的影响。静脉注射API013470mg或100mg.kg显著降低血浆TXB2浓度,其降低2率分别为38.8%和51.6%,API0134明显抑制ADP诱导的大鼠血小板聚集和TXB2生成,抑制率分别为27.8%,39.5%,和41.4%,53.6%,两抑制率间呈显著正相关。 相似文献
80.
APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).
Sarju G Mehta Giles D J Watts Jennifer L Adamson Mike Hutton Geanie Umberger Shuling Xiong Sheena Ramdeen Mark A Lovell Virginia E Kimonis Charles D Smith 《Genetics in medicine》2007,9(1):9-13
PURPOSE: Inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia is an adult-onset autosomal dominant illness (IBMPFD) caused by mutations in the valosin-containing protein (VCP) on chromosome 9p21.1-p12. The penetrance of the gene is 82% for myopathy, 49% for Paget's disease, but may be as low as 30% for frontotemporal dementia. Modifier genes could account for decreased frontotemporal dementia penetrance. In this study apolipoprotein-E (APOE) was evaluated for this role in IBMPFD families based on its known modifier effect in Alzheimer's disease. METHODS: From a database of 231 members of 15 families, 174 had APOE genotype available for analysis. Logistic regressions on APOE genotype and frontotemporal dementia were performed, using appropriate covariates. RESULTS AND CONCLUSION: FTD was associated with APOE 4 genotype (P=0.0002), myopathy (P=0.0006), and age (P=0.01), but not microtubule associated protein tau (MAPT) H2 haplotype (P=0.5) or gender (0.09) after adjustment for membership in pedigrees with at least one APOE 4 genotype. These data suggest a potential link between APOE 4 genotype and the specific form of frontotemporal dementia found in IBMPFD. The molecular basis of this link bears further investigation. We did not observe an association of frontotemporal dementia and H2 MAPT haplotype. 相似文献